Search Results - "Peersen, K"

Preventable clinical and psychosocial factors predicted two out of three recurrent cardiovascular events in a coronary population by Sverre, E, Peersen, K, Weedon-Fekjær, H, Perk, J, Gjertsen, E, Husebye, E, Gullestad, L, Dammen, T, Otterstad, J E, Munkhaugen, J

“…The relative importance of lifestyle, medical and psychosocial factors on the risk of recurrent major cardiovascular (CV) events (MACE) in coronary patients'…”
Get full text

Challenges in coronary heart disease prevention - experiences from a long-term follow-up study in Norway by Sverre, E, Peersen, K, Perk, J, Husebye, E, Gullestad, L, Dammen, T, Otterstad, J E, Munkhaugen, J

“…To determine longitudinal changes in lifestyle behaviour and lipid management in a chronic coronary heart disease (CHD) population. A multi-centre cohort study…”
Get more information

Plasma concentration of atorvastatin metabolites correlates with low‐density lipoprotein cholesterol reduction in patients with coronary heart disease by Sverre, E., Munkhaugen, J., Kristiansen, O., Weedon‐Fekjær, H., Peersen, K., Gjertsen, E., Gullestad, L., Bergan, S., Husebye, E., Vethe, N. T.

“…In this exploratory study from a randomized double‐blinded crossover trial including 70 patients with coronary heart disease and self‐perceived muscular side…”
Get full text

Clinical factors, psychological factors and beliefs about statin use in patients with coronary heart disease and self-perceived muscle side-effects by Peersen, K, Sverre, E, Kristiansen, O, Fagerland, M, Gullestad, L, Otterstad, J.E, Dammen, T, Munkhaugen, J

“…Abstract Background Statin associated muscle symptoms (SAMS) are commonly reported and constitute the principal reason for statin non-adherence and/or…”
Get full text

Drug related metabolites and genetic polymorphisms predict low low-density lipoprotein cholesterol response to atorvastatin treatment in patients with coronary heart disease by Munkhaugen, J, Sverre, E, Kristiansen, O, Fagerland, M.W, Peersen, K, Bergan, S, Gullestad, L, Husebye, E, Vethe, N.T

“…Abstract Background There is considerable individual variation in the low-density lipoprotein cholesterol (LDL-C) reduction at all classes and doses of…”
Get full text

Low-density lipoprotein cholesterol increased significantly after short-term discontinuation of atorvastatin, but did not correlate with plasma drug concentrations by Sverre, E, Piourevonas, J, Kristiansen, O, Peersen, K, Lauritzen, T, Husebye, E, Fagerland, M, Vethe, NT, Munkhaugen, J

“…Abstract Funding Acknowledgements Type of funding sources: Foundation. Main funding source(s): The Dam foundation Introduction Statin non-adherence remains a…”
Get full text

Atorvastatin lactone/acid ratios are promising biomarkers for statin dependent muscular side effects in patients with coronary heart disease by Lauritzen, T, Munkhaugen, J M, Peersen, K P, Kristiansen, O K, Sverre, E S, Andersen, A M A, Jensen, E P J, Bergan, S B, Husebye, E H, Vethe, N T V

“…Abstract Funding Acknowledgements Type of funding sources: Public hospital(s). Main funding source(s): Vestre Viken Hospital Trust. Background In clinical…”
Get full text

P4398Potentially modifiable clinical and psychosocial factors associated with recurrent cardiovascular events in an outpatient coronary population by Sverre, E, Peersen, K, Weedon-Fekjar, H, Perk, J, Gjertsen, E, Husebye, E, Otterstad, J E, Gullestad, L, Dammen, T, Munkhaugen, J

“…Abstract Background Regular assessment and management of lifestyle, biological and psychosocial factors are recommended in coronary patients. The relative…”
Get full text

High but not low self-reported statin adherence was confirmed by a novel method based on plasma-statin measurements in coronary outpatients by Kristiansen, O, Sverre, E, Peersen, K, Fagerland, MW, Gjertsen, E, Gullestad, L, Perk, J, Dammen, T, Husebye, E, Vethe, NT, Munkhaugen, J

“…Abstract Funding Acknowledgements Type of funding sources: Public hospital(s). Main funding source(s): Helse Sør-Øst Background To what extent self-reported…”
Get full text

Tailored clinical management after blinded statin challenge improved long-term lipid control in coronary patients with self-perceived muscle side-effects by Sverre, E, Peersen, K, Kristiansen, O, Fagerland, MW, Perk, J, Husebye, E, Vethe, NT, Dammen, T, Munkhaugen, J

“…Abstract Funding Acknowledgements Type of funding sources: Public hospital(s). Main funding source(s): Helse Sør-Øst, Vestre Viken Trust Background Statin…”
Get full text

Clinical and pharmacological characteristics in plasma and mononuclear blood cells in patients with coronary heart disease and low statin tolerance by Lauritzen, T, John Munkhaugen, JM, Kari Peersen, KP, Elise Sverre, ES, Oscar Kristiansen, OK, Elena Prunes Jensen, EPJ, Stein Bergan, SB, Einar Husebye, EH, Nils Tore Vethe, NTV

“…Abstract Funding Acknowledgements Type of funding sources: Public hospital(s). Main funding source(s): Vestre Viken Hospital Trust Background Statin-associated…”
Get full text

Physical performance is associated with markers of vascular inflammation in patients with coronary heart disease by Schumacher, A., Peersen, K., Sommervoll, L., Seljeflot, I., Arnesen, H., Otterstad, J. E.

Get full text